cyclosporine and Hepatic Veno Occlusive Disease

cyclosporine has been researched along with Hepatic Veno Occlusive Disease in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (46.67)	18.2507
2000's	4 (26.67)	29.6817
2010's	3 (20.00)	24.3611
2020's	1 (6.67)	2.80

Authors

Authors	Studies
Hiratoko, K; Inoue, M; Kanamori, T; Mori, M; Morio, T; Mouri, M; Nishino, I; Okiyama, N; Okubo, M; Shimizu, M; Tanaka, E	1
Feng, XW; Geng, L; Shen, T; Zheng, SS	1
Bleyzac, N	1
Jorge, S; Lopes, JA	1
Davies, SM; Jodele, S; Lawrence, J; Marsh, RA; Myers, KC	1
Fujimura, A; Hishikawa, S; Kawarasaki, H; Kitamura, T; Mizuta, K; Ohmori, M; Sakamoto, K; Sudoh, T; Sugimoto, K; Yamauchi, H	1
Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K	1
Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R	1
Bearman, SI; Hill, HA; Hinds, MS; McDonald, GB; Shen, DD	1
Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D	1
Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E	1
Fritsche, H; Ippoliti, C; Khouri, I; Körbling, M; Przepiorka, D; Warkentin, D; Woo, M	1
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R	1
Anaissie, E; Barri, YM; Pulla, B	1
de Soria, VG; Fernández-Rañada, JM; Figuera, A; Font, P; Gruss, E; Sánchez, S; Sanz-Rodriguez, C; Tomis, JF	1

Reviews

3 review(s) available for cyclosporine and Hepatic Veno Occlusive Disease

Article	Year
Acute kidney injury following HCT: incidence, risk factors and outcome. Bone marrow transplantation, 2011, Volume: 46, Issue:11 Topics: Acute Kidney Injury; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Myeloablative Agonists; Risk Factors; Transplantation Conditioning; Treatment Outcome	2011
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone marrow transplantation, 1997, Volume: 20, Issue:12 Topics: Acute Kidney Injury; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Incidence; Infections; Male; Methylprednisolone; Middle Aged; Patient Compliance; Retrospective Studies; Seizures; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	1997
Acute renal failure following bone marrow transplantation. Renal failure, 1998, Volume: 20, Issue:3 Topics: Acute Kidney Injury; Bone Marrow Transplantation; Cyclosporine; Hepatic Veno-Occlusive Disease; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Time Factors; Tumor Lysis Syndrome	1998

Trials

1 trial(s) available for cyclosporine and Hepatic Veno Occlusive Disease

Article	Year
A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. British journal of haematology, 1993, Volume: 84, Issue:4 Topics: Adult; Alprostadil; Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Drug Interactions; Hepatic Veno-Occlusive Disease; Humans; Middle Aged	1993

Other Studies

11 other study(ies) available for cyclosporine and Hepatic Veno Occlusive Disease

Article	Year
Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report. Modern rheumatology case reports, 2023, 06-19, Volume: 7, Issue:2 Topics: Child, Preschool; Cyclophosphamide; Cyclosporine; Dermatomyositis; Hepatic Veno-Occlusive Disease; Humans; Macrophage Activation Syndrome; Male; Thrombotic Microangiopathies	2023
Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. World journal of gastroenterology, 2015, May-28, Volume: 21, Issue:20 Topics: Adult; Biopsy; Cyclosporine; Drug Substitution; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Predictive Value of Tests; Risk Factors; Tacrolimus; Tomography, X-Ray Computed; Treatment Outcome	2015
The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine. Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:6 Topics: Bayes Theorem; Busulfan; Child; Computer Simulation; Cyclosporine; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Models, Biological; Myeloablative Agonists; Treatment Outcome	2008
High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:3 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Fibrinolytic Agents; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infant; Liver; Male; Methylprednisolone; Myeloablative Agonists; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous	2013
Hepatic venous stenosis-related reduction of cyclosporin clearance in a pediatric patient after liver transplantation. Therapeutic drug monitoring, 2003, Volume: 25, Issue:3 Topics: Constriction, Pathologic; Cyclosporine; Female; Hepatic Veins; Hepatic Veno-Occlusive Disease; Humans; Infant; Liver Transplantation; Metabolic Clearance Rate	2003
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation	2006
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood, 1995, May-01, Volume: 85, Issue:9 Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin	1995
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD. Bone marrow transplantation, 1996, Volume: 17, Issue:4 Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	1996
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation. European cytokine network, 1996, Volume: 7, Issue:3 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous	1996
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:2 Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus	1998
Plasma endothelin-1 levels after stem cell transplantation. Bone marrow transplantation, 2000, Volume: 26, Issue:11 Topics: Acute Kidney Injury; Adolescent; Adult; Cyclosporine; Endothelin-1; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Middle Aged	2000